KZA kazia therapeutics limited

News: KZA Kazia's Paxalisib Receives Fast Track Designation From FDA For Treatment Of Solid Tumor...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 6 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY
    • KAZIA THERAPEUTICS LTD - FURTHER DATA FROM ONGOING PHASE 1 STUDY IS EXPECTED IN 1Q CY2024
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.